The use of dopamine agonists in the treatment of schizophrenia

Neuropharmacology. 1981 Dec;20(12B):1309-13.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Adolescent
  • Adult
  • Apomorphine / adverse effects
  • Apomorphine / therapeutic use*
  • Clinical Trials as Topic
  • Dopamine / physiology*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Psychiatric Status Rating Scales
  • Schizophrenia / drug therapy*
  • Schizophrenic Psychology

Substances

  • Apomorphine
  • Dopamine